37th Annual Miami Breast Cancer Conference®

Fontainebleau Miami Beach
4441 Collins Avenue
Miami Beach, FL 33140

The Conference will go on as scheduled!


Physicians’ Education Resource®, LLC, understands the concerns surrounding the outbreak and spread of the coronavirus (COVID-19) currently affecting several countries. After monitoring the situation and information being shared by the CDC, and taking into account current travel restrictions, we have decided that the 37th Annual Miami Breast Cancer Conference® will go on as scheduled. Be assured that there is nothing more important to us than the safety of our participants; therefore, we have worked with our host hotel and taken steps to implement additional precautions on-site to keep our attendees safe at this year’s conference. We look forward to seeing you there.


37th Annual Miami Breast Cancer Conference® Overview

Breast cancer represents a complicated family of diseases for which detection, diagnosis, and multimodal management strategies are continually evolving. With each lesson learned about the biology of these diseases and with each improvement to the standards of care, new questions, challenges, and controversies arise. Therefore, practice-focused education that enables you to integrate the highest-quality methodologies into your clinic is essential. For 37 years, the multidisciplinary Miami Breast Cancer Conference® has met this educational need—bringing together surgical, medical, and radiation oncologists, as well as geneticists, pathologists, radiologists, and supportive care specialists—to improve the care received by patients with breast cancer.

In March 2020, the 37th Annual Miami Breast Cancer Conference® will continue this tradition and feature the innovative programming and top-notch presentations for which this conference is known. This year’s program will feature world-class tumor board panels, multidisciplinary meet-the-experts small-group breakout sessions, poster talks, a patient-communication workshop, and more time for networking in the afternoons. Topics on the agenda include contemporary management issues, physician burnout, evidence-based alternative medicine, real-world outcomes, treatment de-escalation, patient-centered care, and much, much more. Please join us at the 37th Annual Miami Breast Cancer Conference®. Register today!

Hear it on Friday, use it on Monday


Benefits of Attending the 37th Annual Miami Breast Cancer Conference®

  • Network with your peers and world-renowned thought leaders
  • Ask world-renowned thought leaders your important questions
  • Apply the latest evidence, therapies, and strategies in your practice
  • Gain expert perspectives and clarity on areas of clinical uncertainty and controversy
  • Improve the patient-centered, state-of-the-art care you provide to your patients

Target Audience

This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other healthcare professionals interested in the treatment of breast cancer are also invited to attend.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AbbVie Inc.; Athenex; AstraZeneca; Celgene Corporation; Daiichi Sankyo, Inc.; Eisai Inc.; Genentech; Genomic Health, Inc.; KCI USA, Inc.; MacroGenics, Inc.; Merck Sharp & Dohme Corp; Novartis Pharmaceuticals Corporation; Pacira Pharmaceuticals, Inc.; Pfizer; Puma Biotechnology, Inc.; and Seattle Genetics, Inc.

Accreditation/ Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 26.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 26.0 Contact Hours.

Mini Symposium: Earn up to 5.0 AMA PRA Category 1 Credits™ (5.0 Contact Hours)

Main Conference: Earn up to 21.0 AMA PRA Category 1 Credits™ (21.0 Contact Hours)

Learning Objectives

  • Incorporate evidence-based molecular and genomic biomarkers, multi-gene prognostic assays, and tumor subtype information, as appropriate to guide clinical decision-making and optimize outcomes for individual patients
  • Summarize expert guidelines and evidence from clinical trials that supports the use of genomic and molecular tools to individualize and inform treatment decisions for patients with breast cancer
  • Implement evidence-based multimodal treatment strategies, integrating surgery, radiation, and systemic therapy when appropriate, to ensure optimal outcomes for patients with non-metastatic breast cancer
  • Coordinate a multidisciplinary approach to prevent, mitigate, or manage treatment-related adverse events for patients with breast cancer to optimize outcomes
  • Integrate recent clinical trial data and expert guidelines regarding systemic therapies into treatment planning in order to provide evidence-based state-of-the-art care for patients with breast cancer
  • Identify ongoing clinical trials of emerging agents and strategies that offer additional treatment options for patients with breast cancer

Program Chair

Patrick I. Borgen, MD
Chair, Department of Surgery
Maimonides Medical Center
Brooklyn, NY